MicroPort CardioFlow Medtech Corporation (HKG:2160)
0.7800
0.00 (0.00%)
Feb 11, 2026, 4:08 PM HKT
HKG:2160 Revenue
MicroPort CardioFlow Medtech had revenue of 229.10M CNY in the half year ending June 30, 2025, with 29.85% growth. This brings the company's revenue in the last twelve months to 367.53M, down -4.02% year-over-year. In the year 2024, MicroPort CardioFlow Medtech had annual revenue of 361.57M with 7.54% growth.
Revenue (ttm)
367.53M CNY
Revenue Growth
-4.02%
P/S Ratio
12.33
Revenue / Employee
881.37K CNY
Employees
417
Market Cap
4.97B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 361.57M | 25.35M | 7.54% |
| Dec 31, 2023 | 336.22M | 85.19M | 33.94% |
| Dec 31, 2022 | 251.03M | 50.21M | 25.00% |
| Dec 31, 2021 | 200.81M | 96.88M | 93.21% |
| Dec 31, 2020 | 103.93M | 82.43M | 383.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Isotope & Radiation | 8.35B |
| AK Medical Holdings | 1.52B |
| LifeTech Scientific | 1.45B |
| Beijing Chunlizhengda Medical Instruments | 1.15B |
| Zylox-Tonbridge Medical Technology | 984.51M |
| MicroPort NeuroScientific | 807.00M |
| Peijia Medical | 731.61M |
| Acotec Scientific Holdings | 649.64M |